Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 1997

View Archived Issues

Zeneca discloses agents for pain associated with inflammation

SCRAS discloses novel topoisomerase inhibitors

Oxford GlycoSciences describes pyrimidine-based glycoconjugates

Agents for infertility described by Novo Nordisk

GH-releasing peptides from Novo Nordisk

U.S. researchers reveal agents for reversing MDR

Korean researchers investigate antisecretory agents

Novo Nordisk prepares compounds with high affinity for 5-HT2C receptors

Antiherpesvirus agents reported by Bio-Mega/Boehringer Ingelheim

Alpha-Beta Technology reports fourth-quarter 1996 and year-end results

Gliatech reports 1996 year-end results

Antiallergic effects of new PDE IV inhibitor described

Japanese pharmaceutical companies to merge

Unexpected phase I results reported for DuP-532

Bayer launches new and improved immune globulin in U.S.

Phase I study of pentosan polysulfate in cancer patients

Watson's analgesic receives FDA approval

Hybritech issued U.S. patent covering monoclonal antibodies

Imiquimod for postviral asthma-like syndrome

Pranlukast for allergic rhinitis

Oral pranlukast and cold air-induced bronchoconstriction

Intravenous pranlukast for mild to moderate asthma

Safety and efficacy of pranlukast in asthma

Effects of montelukast on exercise-induced bronchoconstriction in children

Montelukast effective for chronic asthma

CFC-free Intal comparable to CFC Intal

Dose-response study of CFC-free Azmacort formulation in adult asthmatics

Hemosol's blood substitute advances to phase II

HPA effects of new formulation of Azmacort

Progenitor announces acquisition

NeXstar and Schering AG extend collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...